BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32375879)

  • 1. Increased circulating vascular endothelial growth factor in acute myeloid leukemia patients: a systematic review and meta-analysis.
    Song M; Wang H; Ye Q
    Syst Rev; 2020 May; 9(1):103. PubMed ID: 32375879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased circulating basic fibroblast growth factor levels in acute myeloid leukemia: a meta-analysis.
    Song MZ; Mao YM; Wu J; Pan HF; Ye QL
    Hematology; 2020 Dec; 25(1):186-193. PubMed ID: 32441581
    [No Abstract]   [Full Text] [Related]  

  • 3. Circulating Insulin-like Growth Factor-1 Levels in Patients with Rheumatoid Arthritis: A Meta-analysis.
    Zhao YL; Wu J; Zhang TP; Cheng QY; Wang XP; Gu MM; Pan HF; Ye DQ
    Curr Pharm Des; 2019; 25(10):1091-1098. PubMed ID: 30892152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Circulating Vascular Endothelial Growth Factor Levels With Autoimmune Diseases: A Systematic Review and Meta-Analysis.
    Zhan H; Li H; Liu C; Cheng L; Yan S; Li Y
    Front Immunol; 2021; 12():674343. PubMed ID: 34122433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes.
    Aguayo A; Kantarjian HM; Estey EH; Giles FJ; Verstovsek S; Manshouri T; Gidel C; O'Brien S; Keating MJ; Albitar M
    Cancer; 2002 Nov; 95(9):1923-30. PubMed ID: 12404286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review and meta-analysis of preanalytical factors and methodological differences influencing the measurement of circulating vascular endothelial growth factor.
    Sjöbom U; Nilsson AK; Gyllensten H; Hellström A; Löfqvist C
    PLoS One; 2022; 17(7):e0270232. PubMed ID: 35793362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased flow-mediated dilatation in patients with rheumatoid arthritis: a meta-analysis.
    Xu SZ; Wang P; Guan SY; Li HM; Leng RX; Pan HF; Ye DQ
    Postgrad Med J; 2017 May; 93(1099):260-265. PubMed ID: 27807003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor secretion is an independent prognostic factor for relapse-free survival in pediatric acute myeloid leukemia patients.
    de Bont ES; Fidler V; Meeuwsen T; Scherpen F; Hählen K; Kamps WA
    Clin Cancer Res; 2002 Sep; 8(9):2856-61. PubMed ID: 12231527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Anti-VEGF/VEGFR Agents on Animal Models of Endometriosis: A Systematic Review and Meta-Analysis.
    Liu S; Xin X; Hua T; Shi R; Chi S; Jin Z; Wang H
    PLoS One; 2016; 11(11):e0166658. PubMed ID: 27855197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo.
    Schuch G; Machluf M; Bartsch G; Nomi M; Richard H; Atala A; Soker S
    Blood; 2002 Dec; 100(13):4622-8. PubMed ID: 12453880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Change of vascular endothelial growth factor and its receptors expression in acute myeloid leukemia before and after treatment].
    Zhang JQ; Wang JK; Li YM
    Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):100-2. PubMed ID: 14990052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum vascular endothelial growth factor (VEGF) levels in ischemic stroke patients: a systematic review and meta-analysis of case-control studies.
    Seidkhani-Nahal A; Khosravi A; Mirzaei A; Basati G; Abbasi M; Noori-Zadeh A
    Neurol Sci; 2021 May; 42(5):1811-1820. PubMed ID: 32888077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway.
    Zhang J; Ye J; Ma D; Liu N; Wu H; Yu S; Sun X; Tse W; Ji C
    Carcinogenesis; 2013 Mar; 34(3):667-77. PubMed ID: 23239744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukaemia and myelodysplastic syndrome.
    Verstovsek S; Estey E; Manshouri T; Giles FJ; Cortes J; Beran M; Rogers A; Keating M; Kantarjian H; Albitar M
    Br J Haematol; 2002 Jul; 118(1):151-6. PubMed ID: 12100142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the acute myeloid leukemia cell line OCI/AML-2 by endothelial nitric oxide synthase under the control of a vascular endothelial growth factor signaling system.
    Koistinen P; Siitonen T; Mäntymaa P; Säily M; Kinnula V; Savolainen ER; Soini Y
    Leukemia; 2001 Sep; 15(9):1433-41. PubMed ID: 11516104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactate dehydrogenase, not vascular endothelial growth factor or basic fibroblast growth factor, positively correlates to bone marrow vascularity in acute myeloid leukemia.
    Teng CL; Young JH; Hsu SL; Chou G; Kuo IT; Yu CY; Hwang GY
    J Chin Med Assoc; 2006 Nov; 69(11):534-7. PubMed ID: 17116616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral vascular endothelial growth factor as a novel depression biomarker: A meta-analysis.
    Carvalho AF; Köhler CA; McIntyre RS; Knöchel C; Brunoni AR; Thase ME; Quevedo J; Fernandes BS; Berk M
    Psychoneuroendocrinology; 2015 Dec; 62():18-26. PubMed ID: 26210676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia.
    Padró T; Bieker R; Ruiz S; Steins M; Retzlaff S; Bürger H; Büchner T; Kessler T; Herrera F; Kienast J; Müller-Tidow C; Serve H; Berdel WE; Mesters RM
    Leukemia; 2002 Jul; 16(7):1302-10. PubMed ID: 12094254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukemia.
    Brunner B; Gunsilius E; Schumacher P; Zwierzina H; Gastl G; Stauder R
    J Hematother Stem Cell Res; 2002 Feb; 11(1):119-25. PubMed ID: 11847008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of δ-like ligand 4 and Notch1 in acute myeloid leukemia.
    Zhang J; Ma D; Ye J; Zang S; Lu F; Yang M; Qu X; Sun X; Ji C
    Oncol Rep; 2012 Oct; 28(4):1503-11. PubMed ID: 22858860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.